Shree Ganesh Rem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE414Y01015
  • NSEID:
  • BSEID: 540737
INR
646.95
24.65 (3.96%)
BSENSE

May 25

BSE+NSE Vol: 12.6 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Kopran
Shree Ganesh Rem
Kilitch Drugs
Zim Laboratories
Anuh Pharma
Sigachi Indust.
Themis Medicare
Bharat Parenter.
Fermenta Biotec.
Anlon Healthcare
Influx Health.

Why is Shree Ganesh Remedies Ltd ?

1
Company has a Debt to Equity ratio (avg) of 0.05 times
2
Poor long term growth as Operating profit has grown by an annual rate 16.32% of over the last 5 years
3
Flat results in Mar 26
  • PAT(Latest six months) At Rs 9.36 cr has Grown at -22.06%
  • ROCE(HY) Lowest at 14.23%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.36 times
4
With ROE of 10.9, it has a Expensive valuation with a 4.9 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 4.72%, its profits have fallen by -23%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Market Beating performance in long term as well as near term
  • Along with generating 4.72% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Shree Ganesh Rem should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shree Ganesh Rem for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shree Ganesh Rem
5.04%
0.11
43.51%
Sensex
-6.61%
-0.52
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
17.37%
EBIT Growth (5y)
16.32%
EBIT to Interest (avg)
15.48
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.78
Tax Ratio
26.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
20.65%
ROE (avg)
13.40%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
45
Industry P/E
34
Price to Book Value
4.92
EV to EBIT
32.85
EV to EBITDA
23.03
EV to Capital Employed
4.81
EV to Sales
7.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.64%
ROE (Latest)
10.90%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET SALES(Q)

At Rs 33.20 cr has Grown at 35.90%

PBDIT(Q)

Highest at Rs 11.38 cr.

PBT LESS OI(Q)

Highest at Rs 7.70 cr.

-9What is not working for the Company
PAT(Latest six months)

At Rs 9.36 cr has Grown at -22.06%

ROCE(HY)

Lowest at 14.23%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.36 times

Loading Valuation Snapshot...

Here's what is working for Shree Ganesh Rem

Net Sales - Quarterly
Highest at Rs 33.20 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 33.20 cr has Grown at 35.90%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 11.38 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 7.70 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Shree Ganesh Rem

Profit After Tax (PAT) - Latest six months
At Rs 9.36 cr has Grown at -22.06%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 3.36 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio